The MD-6000 Bladder Scanner is a non-invasive diagnostic tool that measures the amount of urine in the bladder or used to determine how much urine remains in the bladder after urination as a way to ...
A phase 2 trial of enGene's detalimogene voraplasmid in non-muscle invasive bladder cancer (NMIBC) has delivered a positive result, setting it on course for a filing with the FDA next year. The LEGEND ...
Johnson & Johnson has brought its bladder cancer drug TAR-200 to the US market, a year after its prospects were dented by a negative phase 3 readout. The novel formulation of the stalwart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results